0001104659-19-074340.txt : 20191219
0001104659-19-074340.hdr.sgml : 20191219
20191219160237
ACCESSION NUMBER: 0001104659-19-074340
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191126
FILED AS OF DATE: 20191219
DATE AS OF CHANGE: 20191219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufman Howard
CENTRAL INDEX KEY: 0001744424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 191295794
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
a4.xml
4
X0306
4
2019-11-26
0
0001737953
Replimune Group, Inc.
REPL
0001744424
Kaufman Howard
C/O REPLIMUNE GROUP, INC.,
500 UNICORN PARK
WOBURN
MA
01801
0
1
0
0
Chief Medical Officer
Common Stock
2019-11-26
4
M
0
58067
3.3
A
58067
D
Employee Stock Option (right to buy)
3.3
2019-11-26
4
M
0
58067
0
D
2027-09-01
Common Stock
58067
91135
D
On September 1, 2017 the Reporting Person was granted an option to purchase 149,202 shares of the Issuer's common stock, 25% of which vested on September 1, 2018 and the remainder of which vested or will vest in 36 equal monthly installments thereafter.
/s/Robert Coffin, attorney-in-fact
2019-12-19